About Dr. Prashant Chhajed | Advisory Board | Scientific Board | Board of Associates
Combined prednisolone and pirfenidone in
bleomycin-induced lung disease
Back to home page  

Vaidya PJ, Sandeepa HS, Singh T, Susheel Kumar SK, Bhargava R, Ramakrishnan G, Chhajed PN.
Journal of Cancer Research and Therapeutics.July Sep 2016;12(3):1198-1202.


Bleomycin is a cytostatic drug commonly employed in the treatment of Hodgkin's disease, seminomas, and choriocarcinoma. Bleomycin may induce a chronic pulmonary inflammation that may progress to fibrosis. So far, only corticosteroids have been used in the treatment of bleomycin-induced lung disease with variable results. Pirfenidone is an antifibrotic drug that has been approved for the treatment of idiopathic pulmonary fibrosis. We report two cases of bleomycin-induced lung disease treated successfully with pirfenidone and oral corticosteroids.


Back to home page


Top Top 

www.ipmrd.org The Institute of Pulmonology, Medical Research and Development